How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Sell
43
VRTX Quote, Financials, Valuation and Earnings
Last price:
$440.92
Seasonality move
:
9.41%
Day range:
$436.81 - $451.81
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
26.10x
P/S ratio:
10.46x
P/B ratio:
6.98x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
-6.47%
Market cap:
$115.1B
Revenue:
$11B
EPS (TTM):
-$3.92
Vertex Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals
|
05/07/2024 | 10-Q | 10-Q filing on 05/07/2024 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/15/2024 | 10-K | 10-K filing on 02/15/2024 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
11/07/2023 | 10-Q | 10-Q filing on 11/07/2023 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
08/02/2023 | 10-Q | 10-Q filing on 08/02/2023 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
05/02/2023 | 10-Q | 10-Q filing on 05/02/2023 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/10/2023 | 10-K | 10-K filing on 02/10/2023 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/28/2022 | 10-Q | 10-Q filing on 10/28/2022 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
08/05/2022 | 10-Q | 10-Q filing on 08/05/2022 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
05/06/2022 | 10-Q | 10-Q filing on 05/06/2022 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/09/2022 | 10-K | 10-K filing on 02/09/2022 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
07/30/2021 | 10-Q | 10-Q filing on 07/30/2021 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
04/30/2021 | 10-Q | 10-Q filing on 04/30/2021 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/11/2021 | 10-K | 10-K filing on 02/11/2021 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/30/2020 | 10-Q | 10-Q filing on 10/30/2020 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
07/31/2020 | 10-Q | 10-Q filing on 07/31/2020 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
05/01/2020 | 10-Q | 10-Q filing on 05/01/2020 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/13/2020 | 10-K | 10-K filing on 02/13/2020 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/31/2019 | 10-Q | 10-Q filing on 10/31/2019 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
05/01/2019 | 10-Q | 10-Q filing on 05/01/2019 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/13/2019 | 10-K | 10-K filing on 02/13/2019 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/25/2018 | 10-Q | 10-Q filing on 10/25/2018 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
07/26/2018 | 10-Q | 10-Q filing on 07/26/2018 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
04/27/2018 | 10-Q | 10-Q filing on 04/27/2018 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/15/2018 | 10-K | 10-K filing on 02/15/2018 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/30/2017 | 10-Q | 10-Q filing on 10/30/2017 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
07/28/2017 | 10-Q | 10-Q filing on 07/28/2017 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
04/28/2017 | 10-Q | 10-Q filing on 04/28/2017 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/23/2017 | 10-K | 10-K filing on 02/23/2017 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/31/2016 | 10-Q | 10-Q filing on 10/31/2016 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
08/01/2016 | 10-Q | 10-Q filing on 08/01/2016 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
05/03/2016 | 10-Q | 10-Q filing on 05/03/2016 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
02/16/2016 | 10-K | 10-K filing on 02/16/2016 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
10/30/2015 | 10-Q | 10-Q filing on 10/30/2015 | View Form |
|
VRTX
Vertex Pharmaceuticals
|
08/04/2015 | 10-Q | 10-Q filing on 08/04/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Target’s Stock Be in 10 Years?
If you could hop into a time machine and land…
Why Did Stan Druckenmiller Buy DocuSign?
Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
